Literature DB >> 23804894

Magnetic resonance angiography detection of vascular aneurysms in patients with kawasaki disease and coronary artery aneurysms.

Joseph R Casadonte1, Vanessa M Perez, Gary Stapleton, Marguerite M Crawford, Jeffrey P Jacobs, David S Cooper, Gul H Dadlani.   

Abstract

Kawasaki disease is a systemic panvasculitis that causes coronary artery aneurysms in approximately 15% to 25% of untreated patients. Systemic vascular aneurysms may also occur in medium-sized arteries throughout the body and may lead to increased morbidity and mortality in patients with Kawasaki disease. We report a case of diffuse systemic aneurysm formation in a 2-year-old patient with Kawasaki disease with coronary artery aneurysms. Full-body magnetic resonance angiography (MRA) imaging was utilized both in the acute phase and again prior to cardiac catheterization performed at 6 months from the acute illness. The initial MRA detected aneurysmal dilatation of the common and internal iliac arteries bilaterally in the acute phase. Subsequent MRA performed prior to cardiac catheterization 6 months later demonstrated resolution of the iliac artery lesions. Full-body MRA may be useful in screening for associated systemic vascular aneurysms in patients with Kawasaki disease and associated coronary artery aneurysms.

Entities:  

Keywords:  Kawasaki disease; coronary artery aneurysm; iliac artery aneurysm; magnetic resonance angiography

Year:  2010        PMID: 23804894     DOI: 10.1177/2150135110381389

Source DB:  PubMed          Journal:  World J Pediatr Congenit Heart Surg        ISSN: 2150-1351


  2 in total

1.  Unusual imaging presentation of infantile atypical Kawasaki disease.

Authors:  Nishith Kumar; Mahesh Kumar Mittal; Mukul Sinha; Arpita Gupta; Brij Bhushan Thukral
Journal:  Indian J Radiol Imaging       Date:  2016 Jul-Sep

Review 2.  Coronary artery aneurysm combined with other multiple aneurysms at multiple locations: A case report and systematic review.

Authors:  Li-Cheng Jiang; Jia-Yu Cao; Mao Chen
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.